Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Free Report)’s share price was up 1.5% during mid-day trading on Monday . The stock traded as high as $2.03 and last traded at $2.03. Approximately 33,477 shares changed hands during trading, a decline of 98% from the average daily volume of 1,388,685 shares. The stock had previously closed at $2.00.
Hillstream BioPharma Stock Performance
The stock has a 50 day moving average price of $2.06 and a 200 day moving average price of $2.44. The company has a market capitalization of $35.73 million, a P/E ratio of -2.82 and a beta of 3.08.
About Hillstream BioPharma
Hillstream BioPharma, Inc, a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors.
Recommended Stories
- Five stocks we like better than Hillstream BioPharma
- What Are Trending Stocks? Trending Stocks Explained
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- The Significance of Brokerage Rankings in Stock Selection
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- P/E Ratio Calculation: How to Assess Stocks
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Hillstream BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hillstream BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
